Key result
Advanced disease complicates post-CABG non-invasive ischaemia testing but new AI techniques offer future promise.
Why the study?
Performing and interpreting non-invasive ischaemia testing post-CABG is challenging across imaging modalities due to complex pathophysiological mechanisms, and technological advances offer new opportunities to re-evaluate testing value.
This review outlines the technical and physiological challenges of non-invasive ischemia testing in post-CABG patients, emphasizing the need for careful modality selection and interpretation.
Complicates ischaemia assessment after CABG; leaves open whether quantitative AI techniques will improve accuracy pending prospective validation.
Coronary artery bypass graft (CABG) surgery effectively relieves symptoms and improves outcomes. However, patients undergoing CABG surgery typically have advanced coronary atherosclerotic disease and remain at high risk for symptom recurrence and adverse events. Functional non-invasive testing for ischaemia is commonly used as a gatekeeper for invasive coronary and graft angiography, and for guiding subsequent revascularisation decisions. However, performing and interpreting non-invasive ischaemia testing in patients post CABG is challenging, irrespective of the imaging modality used. Multiple factors including advanced multi-vessel native vessel disease, variability in coronary hemodynamics post-surgery, differences in graft lengths and vasomotor properties, and complex myocardial scar morphology are only some of the pathophysiological mechanisms that complicate ischaemia evaluation in this patient population. Systematic assessment of the impact of these challenges in relation to each imaging modality may help optimize diagnostic test selection by incorporating clinical information and individual patient characteristics. At the same time, recent technological advances in cardiac imaging including improvements in image quality, wider availability of quantitative techniques for measuring myocardial blood flow and the introduction of artificial intelligence-based approaches for image analysis offer the opportunity to re-evaluate the value of ischaemia testing, providing new insights into the pathophysiological processes that determine outcomes in this patient population.
No takes yet. Share an insight, caveat, or question.
Seraphim et al. (2021) conducted a review in Prior Coronary Artery Bypass Graft (CABG) Surgery. Non-invasive ischaemia testing was evaluated. Non-invasive ischaemia testing in post-CABG patients is complicated by advanced multi-vessel disease and altered hemodynamics, though new quantitative and AI-based techniques offer future promise.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: